UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000030959 |
|---|---|
| Receipt number | R000035354 |
| Scientific Title | Study on development of thyroid dose assessment method considering individual thyroid size |
| Date of disclosure of the study information | 2018/01/24 |
| Last modified on | 2021/07/27 23:15:50 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Study on development of thyroid dose assessment method considering individual thyroid size
Acronym
Study on development of thyroid dose assessment method considering individual thyroid size
Scientific Title
Study on development of thyroid dose assessment method considering individual thyroid size
Scientific Title:Acronym
Study on development of thyroid dose assessment method considering individual thyroid size
Region
| Japan |
Condition
Condition
Healthy person
Classification by specialty
| Adult |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To improve the accuracy of internal dose estimations using numerical phantoms
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Comparison in the detector's response between numerical phantoms and a physical phantom
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
Single arm
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
1
Purpose of intervention
Prevention
Type of intervention
| Device,equipment |
Interventions/Control_1
MRI photography
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 60 | years-old | > |
Gender
Male and Female
Key inclusion criteria
No history of thyroid disease
Key exclusion criteria
Persons with contraindication to MRI examinations
Target sample size
40
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Osamu Kurihara |
Organization
National Institute for Quantum and Radiological Institute of Radiological Science and Technology
Division name
Dept. of Radiation Measurement and Dose Assessment
Zip code
Address
4-9-1 Anagawa, Inage-ku, Chiba-city, CHIBA
TEL
043-206-4734
kurihara.osamu@qst.go.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Osamu Kurihara |
Organization
National Institute for Quantum and Radiological Institute of Radiological Science and Technology
Division name
Dept. of Radiation Measurement and Dose Assessment
Zip code
Address
4-9-1 Anagawa, Inage-ku, Chiba-city, CHIBA 263-8555 Japan
TEL
043-206-4734
Homepage URL
kurihara.osamu@qst.go.jp
Sponsor or person
Institute
National Institute for Quantum and Radiological Institute of Radiological Science and Technology
Institute
Department
Personal name
Funding Source
Organization
National Institute for Quantum and Radiological Institute of Radiological Science and Technology
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2018 | Year | 01 | Month | 24 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2017 | Year | 12 | Month | 26 | Day |
Date of IRB
| 2018 | Year | 01 | Month | 19 | Day |
Anticipated trial start date
| 2018 | Year | 03 | Month | 01 | Day |
Last follow-up date
| 2020 | Year | 10 | Month | 14 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
| 2021 | Year | 03 | Month | 31 | Day |
Other
Other related information
Management information
Registered date
| 2018 | Year | 01 | Month | 23 | Day |
Last modified on
| 2021 | Year | 07 | Month | 27 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000035354
